Patents by Inventor Evert Njomen

Evert Njomen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SMALL MOLECULE ENHANCEMENT OF 20S PROTEASOME ACTIVITY TARGETS INTRINSICALLY DISORDERED PROTEINS
    Publication number: 20230002335
    Abstract: The disclosure is directed to compounds of the formula (I) and (II) and uses of such compounds to treat, among other conditions, neurodegenerative diseases and cancers.
    Type: Application
    Filed: February 14, 2022
    Publication date: January 5, 2023
    Inventors: Jetze J. Tepe, Theresa A. Lansdell, Evert Njomen, Corey Lee Jones
  • Substituted phenothiazines as proteasome activators
    Patent number: 11358942
    Abstract: The disclosure is directed to compounds of the formula (I): and uses of such compounds to treat neurodegenerative diseases and cancers.
    Type: Grant
    Filed: June 4, 2018
    Date of Patent: June 14, 2022
    Assignee: Board of Trustees of Michigan State University
    Inventors: Jetze J. Tepe, Theresa A. Lansdell, Evert Njomen, Corey Lee Jones
  • SMALL MOLECULE PROTEASOME ACTIVATORS AND USES THEREOF
    Publication number: 20200165216
    Abstract: The disclosure is directed to compounds of the formula (I) and (II) and uses of such compounds to treat, among other conditions, neurodegenerative diseases and cancers.
    Type: Application
    Filed: June 4, 2018
    Publication date: May 28, 2020
    Inventors: Jetze J. Tepe, Theresa A. Landsdell, Evert Njomen, Corey Lee Jones